Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
April 25, 2025 13:17 ET | Source: Pyxis Oncology Gene signatures associated…
New Pediatric Dental Office Opens in Oceanside
Grand Opening Event Underscores Commitment to Improving Children’s Oral Health in Oceanside…
DOWNTOWN FARMERS’ MARKET TO KICK OFF 50TH SEASON ON SATURDAY, MAY 3
GREATER DES MOINES, Iowa, April 11, 2025 /PRNewswire/ -- Opening day for…
FIS goes from strength to strength on social media
Apr 08, 2025 - The 2024/25 World Cup season saw FIS break…
Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
--Data presented at the American College of Cardiology Annual Scientific Session show…
137th Canton Fair Promotes Innovation and Trade in Hong Kong and Macao, Bringing Regional Economy to New Heights
GUANGZHOU, China, March 28, 2025 /PRNewswire/ -- The 137th Canton Fair, set…
Woodside to Divest Greater Angostura Assets to Perenco
HOUSTON--(BUSINESS WIRE)--Woodside has entered into an agreement with Perenco to divest its…
Rapid7 Appoints Three New Board Members
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a…
Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis
Significantly more patients treated with Sotyktu achieved ACR and PASI response rates…
Empowering Women in Crypto: BitMarts Commitment Beyond International Womens Day
Mahe, Seychelles , March 07, 2025 (GLOBE NEWSWIRE) -- Women are making…